As more regulatory professionals adopt artificial intelligence (AI) tools as part of their jobs, a panel of experts who spoke ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
A top US Food and Drug Administration (FDA) official stated that the midterm congressional election results will not likely ...
BARCELONA – As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' jobs but will instead help them work more efficiently and dedicate ...
As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
Moderator Claire D'Abreu-Hayling (left) and FDA's Sarah Yim participate in fireside chat. (Photo: Joanne S. Eglovitch) BETHESDA, MD – Sarah Yim, director of the US Food and Drug Administration’s (FDA) ...
BETHESDA, MD – Sarah Yim, director of the US Food and Drug Administration’s (FDA) Office of Therapeutic Biologics and Biosimilars in the Office of New Drugs, emphasized that the agency is actively ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results